Kota Envoclean Profile
Key Indicators
- Authorised Capital ₹ 70.00 K
- Paid Up Capital ₹ 70.00 K
- Company Age 6 Year, 11 Months
- Last Filing with ROC 31 Mar 2021
- Revenue Growth %
- Profit Growth -264.13%
- Ebitda -264.13%
- Net Worth -40.25%
- Total Assets -9.59%
About Kota Envoclean
Kota Envoclean Private Limited (KEPL) is a Private Limited Indian Non-Government Company incorporated in India on 21 February 2018 (Six years and 11 months 12 days old ). Its registered office is in Kota, Rajasthan, India.
The Company is engaged in the Environment Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 70.00 K and a paid-up capital of Rs 70.00 K , as per Ministry of Corporate Affairs (MCA) records.
Suresh Goyal, Kewal Dang, Jaswant Singh, and One other member serve as directors at the Company.
Company Details
-
Location
Kota, Rajasthan, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74999RJ2018PTC060275
-
Company No.
060275
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
21 Feb 2018
-
Date of AGM
30 Nov 2021
-
Date of Balance Sheet
31 Mar 2021
-
Listing Status
Unlisted
-
ROC Code
Roc Jaipur
Industry
Who are the key members and board of directors at Kota Envoclean?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sanjay Jaiswal
|
Director | 21-Feb-2018 | Current |
|
Suresh Goyal
|
Director | 21-Feb-2018 | Current |
|
Kewal Dang
|
Director | 21-Feb-2018 | Current |
|
Jaswant Singh
|
Director | 21-Feb-2018 | Current |
Financial Performance of Kota Envoclean.
Kota Envoclean Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 264.13% decrease in profit. The company's net worth observed a substantial decline by a decrease of 40.25%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kota Envoclean?
In 2018, Kota Envoclean had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Goyal Endoscopy Surgery And Research Center Private LimitedSuresh Goyal is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Kota Envoclean?
Unlock and access historical data on people associated with Kota Envoclean, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kota Envoclean, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kota Envoclean's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
